You have 9 free searches left this month | to do more
Showing 1 - 25 of
6,260 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
R
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families
Recruiting
  • Clinical Stage 0 Cutaneous Melanoma AJCC v8
  • +21 more
  • Informational Intervention
  • Survey Administration
  • New Brunswick, New Jersey
  • +1 more
2022-04-06
Apr 6, 2022
H
Pre Transplantation Melanoma - 2020
Completed
  • Malignant Melanoma
  • patient with melanoma pre transplantation
  • Lyon, Rhone, France
    service de dermatologie - hopital Edouard Herriot
2021-12-09
Dec 9, 2021
N
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
Not yet recruiting
  • Anal Melanoma
  • +20 more
  • (no location specified)
2022-03-08
Mar 8, 2022
M
Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma
Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +12 more
  • Recombinant Vesicular Stomatitis Virus-expressing Interferon-beta and Tyrosinase Related Protein 1
  • Jacksonville, Florida
  • +1 more
2021-11-03
Nov 3, 2021
M
Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Recruiting
  • Metastatic Melanoma
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2022-03-11
Mar 11, 2022
C
Intralesional Influenza Vaccine for the Treatment of Stage I, II, and IV Melanoma
Recruiting
  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • +8 more
  • Ipilimumab
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2021-09-13
Sep 13, 2021
F
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma or Hormone Receptor Positive Her2 Negative Metastatic Refractory Breast Cancer
Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-04-04
Apr 4, 2022
H
Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma
Recruiting
  • Melanoma
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2022-01-18
Jan 18, 2022
K
Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma
Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • Beta-Glucan
  • Louisville, Kentucky
    University of Louisville
2022-01-07
Jan 7, 2022
V
The Impact of Melanoma and Drug Treatment in the Real World
Recruiting
  • Melanoma
    • Oxford, United Kingdom
      Vitaccess Ltd
    2021-10-05
    Oct 5, 2021
    D
    Dendritic Cell Activating Scaffold in Melanoma
    Active, not recruiting
    • Melanoma
    • WDVAX
    • Boston, Massachusetts
    • +1 more
    2022-02-22
    Feb 22, 2022
    M
    Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases
    Recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    2022-02-10
    Feb 10, 2022
    M
    Radiation and Combination Immunotherapy for Melanoma
    Active, not recruiting
    • Metastatic Melanoma
    • Aldesleukin: All Patients
    • +3 more
    • Burnsville, Minnesota
      University of Minnesota Masonic Cancer Center
    2022-02-25
    Feb 25, 2022
    C
    Community Based Strategies for Early Detection of Melanoma
    Not yet recruiting
    • Melanoma
    • Community Based Strategies for Early Detection of Melanoma
    • (no location specified)
    2022-02-08
    Feb 8, 2022
    M
    Melanoma Surveillance Photography (MSP) to Improve Early Detection of Melanoma in Ultra-high and High Risk Patients
    Recruiting
    • Melanoma
    • +2 more
    • 2D or 3D Melanoma Surveillance Photography
    • Newcastle, New South Wales, Australia
    • +7 more
    2022-03-15
    Mar 15, 2022
    C
    Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma
    Recruiting
    • Melanoma
    • Cleveland, Ohio
    • +1 more
    2022-02-10
    Feb 10, 2022
    D
    Overcoming Primary Resistance to Immunotherapy in Metastatic Melanoma
    Not yet recruiting
    • Malignant Melanoma
    • +4 more
    • (no location specified)
    2022-03-31
    Mar 31, 2022
    R
    Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma
    Active, not recruiting
    • Metastatic Melanoma
    • +8 more
    • Aldesleukin
    • +2 more
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    2021-09-20
    Sep 20, 2021
    M
    pRospective Evaluation of Clinical Outcomes in Patients With metAsTatIс melanOma Treated With dabrafeNib and trAmetinib in reaL practicE
    Recruiting
    • Melanoma Stage III
    • +2 more
    • Moscow, Russian Federation
    • +1 more
    2021-12-23
    Dec 23, 2021
    U
    Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma
    Not yet recruiting
    • Melanoma (Skin)
    • Melanoma, Uveal
    • Oxford, United Kingdom
      Oxford University Hospitals NHS Trust
    2022-03-29
    Mar 29, 2022
    C
    Safety and Efficacy of DCB-BO1301 in Advanced Melanoma
    Not yet recruiting
    • Advanced Melanoma
    • (no location specified)
    2022-03-17
    Mar 17, 2022
    H
    Axitinib + Ipilimumab in Advanced Melanoma
    Recruiting
    • Melanoma
    • Tampa, Florida
      Moffitt Cancer Center
    2022-01-19
    Jan 19, 2022
    M
    CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma
    Recruiting
    • Melanoma
    • Melanoma Stage III
    • PET Scan
    • +3 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    2022-04-04
    Apr 4, 2022
    A
    Neoadjuvant PD-1 Blockade in Patients With Stage IIB/C Melanoma
    Recruiting
    • Melanoma
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    2022-01-05
    Jan 5, 2022
    U
    Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
    Recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • San Francisco, California
      University of California, San Francisco
    2021-12-03
    Dec 3, 2021